What we can learn from the virus debate.

Under the title: "La Ola - was that the "perfect" wave?" our management consultant Dr. Ralf Hess gave an interview to the UNIversalis newspaper.
Munich, 3 August 2020.

Under the title: "La Ola - was that the "perfect" wave?" our management consultant Dr. Ralf Hess gave an interview to the UNIversalis newspaper.

In an interview with the UNIversalis newspaper, virologist and immunologist Dr Ralf Hess provides information about the current state of the corona situation in Germany. He talks about economic consequences and how the population should behave. But he also talks about what a virus is, how it is transmitted to humans. How a vaccine is developed and whether or not we are facing a second wave.

You can find the article under the following link.

Read here.

Share article.

Facebook
Twitter
LinkedIn
XING
WhatsApp
E-mail

Persons to the article.

Dr Ralf Hess

Principal Management Consultant

Dr Ralf Hess studied biology at the Albert-Ludwigs-University of Freiburg and received his doctorate at the Institute of Virology. Dr. Hess has many years of experience in the development of medical devices and medicinal products as well as their combination, in laboratory analytics and their quality assurance. The quality expert has established, implemented and maintained QM systems according to ISO and GxP for various application areas. The customer service portfolio ranges from manufacturers of classical and biological drugs, medical device companies and vaccine manufacturers to immunohistochemical, immunological, molecular biological and serological diagnostic laboratories. Dr. Hess is active worldwide as an auditor in the GxP/ISO area and has many years of experience in FDA remediation projects and the regulatory development of combination products (drug device products).
Dr. Ralf Hess supports Entourage as Principal Management Consultant.

Newsletter.

Read more.

European Healthcare Autonomy. Lessons Learned from Corona.
What the EU must do to bring the pan-European health system into ...
Repurposing of drugs against SARS-CoV-2.
In addition to the development of new drugs against the coronavirus, ...
Dr Ralf Hess et al, published. Article on the implementation of MDR & IVDR into national law.
Entourage Principal Project Consultant Dr Ralf Hess publishes article on ...
The future of the generics and biosimilars industry.
What is the future for the generics and biosimilars industry? Are there ...
"SOCIAL DISTANCING" - a "lesson learned" or a "learning lesson"?
The "Corona crisis" calls for tough measures. These include so-called non-pharmaceutical interventions, ...